FibroGen

+$0.32 (+2.46%) Today
+$0.27 (+2.03%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell FibroGen and other ETFs, options, and stocks.

About FGEN

FibroGen, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It focuses on the hypoxia-inducible factor and connective tissue growth factor biology to develop medicines for the treatment of anemia, fibrotic disease, and cancer.

CEO
Enrique A. Conterno
Employees
599
Headquarters
San Francisco, California
Founded
1993

FGEN Key Statistics

Market Cap
2.32B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
3.24M
High Today
$13.60
Low Today
$12.98
Open Price
$13.14
Volume
912.46K
52 Week High
$57.21
52 Week Low
$12.54

FGEN Earnings

-$1.12
-$0.63
-$0.14
$0.35
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Available Aug 9, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure